Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Heparin-Coated Coronary Stents.

van Der Giessen WJ1, van Beusekom HM, Larsson

  • 1Thoraxcenter, Erasmus University, Dijkigt dr. Molewatersplein 40, 3015 GD Rotterdam, The Netherlands.

Current Interventional Cardiology Reports
|November 30, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Authors' reply

The British journal of surgery·2000
Same author

Restenosis and Brachytherapy.

Current interventional cardiology reports·2000
Same author

Endovascular brachytherapy in coronary arteries: the Rotterdam experience.

Cardiovascular radiation medicine·2000
Same author

Recombination of simple molecular ions studied in storage ring: dissociative recombination of H2O+

Faraday discussions·2000
Same author

Time-resolved X-Ray diffraction from coherent phonons during a laser-induced phase transition

Physical review letters·2000
Same author

Clinical and Angiographic Results with the Multi-Linkª Coronary Stent System Ñ The West European Stent Trial (WEST).

The Journal of invasive cardiology·2000
Same journal

Rashkind and Clamshell Device Closure of Ventricular Septal Defect.

Current interventional cardiology reports·2001
Same journal

The Role of the 'Sideris' Devices in the Occlusion of Ventricular Septal Defects.

Current interventional cardiology reports·2001
Same journal

A Comparison of Tirofiban and Abciximab in Patients Undergoing Coronary Stent Implantation: Rationale, Design, and Results of the TARGET Trial.

Current interventional cardiology reports·2001
Same journal

Diabetes and Coronary Intervention: Special Considerations for Antithrombotic Therapy.

Current interventional cardiology reports·2001
Same journal

'Facilitated' PCI for Acute MI: PCI with Lysis and Platelet Inhibition.

Current interventional cardiology reports·2001
Same journal

Restenosis and Reocclusion after Recanalization of an Occluded Coronary Artery: Is There a Light at the End of This Tunnel?

Current interventional cardiology reports·2001
See all related articles

Heparin-coated stents show low thrombosis rates, even in acute coronary syndromes. While large trials are needed to confirm benefits over non-coated stents, they have advanced stent therapy in cardiology.

Area of Science:

  • Interventional Cardiology
  • Biomaterials Science

Background:

  • Early bare-metal stents had unfavorable outcomes before advanced imaging and antiplatelet therapies.
  • Heparin-coated (HC) stents were developed to improve safety and efficacy in coronary interventions.

Purpose of the Study:

  • To evaluate the incidence of stent thrombosis with HC stents.
  • To compare the efficacy of HC stents versus non-coated stents in challenging clinical scenarios.

Main Methods:

  • Review of pilot and randomized trials involving HC stents.
  • Preliminary comparison of available trial data.

Main Results:

  • Pilot and randomized trials demonstrate a low incidence of (sub)acute stent thrombosis with HC stents, even in acute coronary syndromes.

Related Experiment Videos

  • HC stents may be as effective as non-coated stents combined with abciximab therapy.
  • HC stents have facilitated wider adoption of stent therapy in interventional cardiology.

    • Conclusions:

    • Heparin-coated stents exhibit a low thrombosis rate, offering a safe option in complex cases.
    • While definitive clinical superiority over non-coated stents requires further large-scale trials, HC stents have significantly contributed to the advancement of coronary stenting.
    • The development of HC stents has played a crucial role in the increased utilization and acceptance of stent therapy for ischemic heart disease.